Načítá se...
Pseudotumor cerebri in patient on leuprolide acetate for central precocious puberty
BACKGROUND: Gonadotropin releasing hormone agonists (GnRHa) are well established as a standard of care for the treatment of central precocious puberty (CPP) worldwide. While numerous delivery systems and routes of administration exist, depot intramuscular injections or sustained-release preparations...
Uloženo v:
| Vydáno v: | Int J Pediatr Endocrinol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7712604/ https://ncbi.nlm.nih.gov/pubmed/33292495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13633-020-00092-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|